1P-LSD 150MCG: A Brief Overview
buy 1P-LSD 150mcg short for 1 Propionyl Lysergic Acid Diethylamide, belongs to the lysergamide family, known for its hallucinogenic and psychedelic properties. It is a derivative and functional analogue of LSD (Lysergic acid diethylamide) and shares similarities with ALD-52.
History and Emergence
1P-LSD first appeared on the online research chemical market in 2015, marketed as a legal alternative to LSD and alongside other lysergamides like ALD-52, ETH-LAD, and AL-LAD. Despite 1P-LSD 150mcg effects availability since then, its origins and original synthesis date remain unknown, lacking any prior record in formal scientific literature.
Chemical Structure and Effects
Effects of taking 1P-LSD 150mcg modifies the LSD molecule by adding a propionyl group to the nitrogen molecule of LSD’s indole ring. Effects of taking 1P-LSD 150mcg is theorized to act as a prodrug for LSD, producing effects such as cognitive euphoria, altered perception of colors, time, sounds, shapes, and hallucinations similar to LSD.
Pharmacology and Safety Considerations
While 1P-LSD is presumed to have a toxicity and risk profile akin to LSD, comprehensive data on its pharmacological properties, metabolism, and toxicity are limited. Users are strongly advised to practice harm reduction when using this substance due to 1P-LSD 150mcg effects psychedelic effects and unknown long-term impacts.
Legal and Regulatory Insights
The emergence of 1P-LSD raised regulatory discussions, echoing early 1988 DEA reports foreseeing potential legal loopholes with 1-alkylated lysergamide derivatives. This foresight suggested these substances might circumvent controlled substance laws governing LSD as a precursor.
Conclusion
1P-LSD continues to attract interest among novel substance users for its psychedelic effects, resembling those of LSD, though detailed scientific scrutiny and data are still lacking. As with all substances of this nature, cautious and informed usage is strongly recommended.
Reviews
There are no reviews yet.